Daiichi Sankyo (Schweiz) AG
- Sector unverified
- Rank 147 / 334
Daiichi Sankyo (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 10 human medicines, which places it 147 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (80 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 10 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Daiichi Sankyo (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 10 human medicines. The table shows 10 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
10 of 10 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| DATROWAY 100 mg | 69801 | A | L01FX35 | 2025-05-28 |
| Enhertu 100 mg | 67967 | A | L01FD04 | 2021-11-29 |
| Lixiana 15 mg | 65149 | B | B01AF03 | 2015-03-31 |
| Nilemdo 180 mg | 67583 | B | C10AX15 | 2020-12-14 |
| Nustendi 180 mg / 10 mg | 67586 | B | C10BA10 | 2020-12-15 |
| Olmetec 10 mg | 55907 | B | C09CA08 | 2005-04-15 |
| Olmetec Plus 20/12 | 57038 | B | C09DA08 | 2005-07-12 |
| Sevikar 20mg/5mg | 58778 | B | C09DB02 | 2008-10-08 |
| Sevikar HCT 20 mg/5 mg/12.5 mg | 61519 | B | C09DX03 | 2011-05-30 |
| VANFLYTA 17.7 mg | 69710 | A | L01EX11 | 2025-03-31 |
Frequently asked questions
How many medicines does Daiichi Sankyo (Schweiz) AG have authorised in Switzerland?
Daiichi Sankyo (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 10 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Daiichi Sankyo (Schweiz) AG based?
We have no confirmed Swiss address for Daiichi Sankyo (Schweiz) AG. We add it as soon as the commercial register or the company confirms it.
Is Daiichi Sankyo (Schweiz) AG a Swissmedic authorisation holder?
Yes. Daiichi Sankyo (Schweiz) AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.